The U.S. healthcare sector experienced a turbulent trading session on April 17, 2025, as UnitedHealth’s UNH earnings disappointment sent ripples through insurer stocks. However, strong gains in ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

The company’s sales and profits have grown at a CAGR of 14.8% and 6.5% respectively over the last five years, reaching Rs 6.8 bn and Rs 0.6 bn in FY24. Its RoE and RoCE have averaged 23% and 31%, ...

Tata Elxsi stock rose despite a 13% fall in Q4 profit. Morgan Stanley has a underweight call on the Tata Group stock.

An investment strategist has highlighted three companies driving the “new age” of healthcare, making them must-watch for ...

Zoetis (NYSE: ZTS) is a leading animal healthcare company offering over 300 medicines, vaccines, and other precision health ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

UnitedHealth Group’s stock dropped sharply on Thursday after the insurance giant slashed its earnings outlook for 2025. The announcement led to a broad drop in the Dow Jones Industrial Average, ...

UnitedHealth Group stock had one of its worst days ever on Thursday after the healthcare giant unexpectedly cut its profit ...

Forian FORA shares rose 53.5% to $3.0 during Thursday's after-market session. The company's market cap stands at $93.5 million. Exicure XCUR shares increased by 17.85% to $10.43. The market value of ...

Pulled lower by UnitedHealth Group’s ( UNH) paring back of its forecasts for 2025—the news left the giant’s shares down ...

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care ...